277DL, Research Associate, Cancer Immunotherapy

Job Code 277DL


Fate Therapeutics is currently seeking a talented and highly motivated Research Associate with a strong background in molecular biology and/or immunology to join a multidisciplinary team dedicated to the discovery of novel cellular therapeutics. The candidate’s primary responsibility will be to generate lentivirus for editing and production of CAR-T cells in support of research efforts at Fate. Experience with current molecular biology techniques used for editing and engineering of hematopoietic cells is highly desired. The successful candidate will have excellent oral and written communication skills. This is a full-time position reporting to a scientist at the Company’s corporate headquarters in San Diego, California.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 277DL.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.